| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.0B | $0.8B | $0.7B | $1.1B | $0.9B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $8.79 | $7.14 | $6.55 | $9.74 | $8.72 | $1.94 | $1.26 | $1.14 |
| EPS (Diluted) | $8.73 | $7.09 | $6.54 | $9.70 | $8.67 | $1.93 | $1.25 | $1.13 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $92.8B | $80.9B | $70.9B | $67.7B | $56.0B | $36.5B | $26.8B | $23.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | $1.0B | $0.5B | $2.7B | $0.4B | $0.5B |
| Total Liabilities | $84.8B | $74.2B | $64.8B | $62.4B | $51.0B | $33.0B | $23.8B | $20.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.7B | $6.7B | $6.1B | $5.4B | $5.0B | $3.4B | $3.0B | $2.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-2.7B | $-2.7B | $-0.3B | $2.2B | $-2.7B | $0.7B | $0.7B | $0.5B |
| Investing Cash Flow | $-9.9B | $-6.0B | $-2.2B | $-13.1B | $-14.7B | $-7.5B | $-3.7B | $-2.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $12.1B | $11.2B | $3.0B | $11.4B | $15.2B | $9.1B | $2.9B | $2.3B |